8156 — Sinopharm Tech Holdings Cashflow Statement
0.000.00%
Last trade - 00:00
- HK$18.37m
- HK$13.68m
- HK$42.84m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -47.9 | -165 | -111 | -94.2 | -11.4 |
Depreciation | |||||
Amortisation | |||||
Non-Cash Items | 14.7 | 153 | 76.8 | 64.4 | 93.1 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -11.7 | 27 | 17.6 | -9.46 | -78.9 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -33.9 | 23.9 | -6.21 | -36.8 | 4.73 |
Capital Expenditures | 0 | -23.4 | -10.1 | -0.121 | 0 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 0.025 | 0.004 | 5.07 | 0.036 | 0.002 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale of Fixed Assets | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.025 | -23.4 | -5.05 | -0.085 | 0.002 |
Financing Cash Flow Items | -2.9 | -14.5 | 20.6 | -2.48 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 36.9 | -0.299 | 12.5 | 32.2 | -4.52 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 1.93 | 0.1 | 0.736 | -4.49 | -1.22 |